4-nitrobenzylthioinosine has been researched along with Aura in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, H; Li, D; Luo, Z; Peng, Y; Qiu, X; Wang, J; Xu, P; Xu, Z; Zhang, J | 1 |
Avoli, M; Drapeau, C; Kostopoulos, G; Olivier, A; Villemeure, JG | 1 |
2 other study(ies) available for 4-nitrobenzylthioinosine and Aura
Article | Year |
---|---|
Nitrobenzylthioinosine mimics adenosine to attenuate the epileptiform discharge of hippocampal neurons from epileptic rats.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Epilepsy; Gene Expression; Hippocampus; Male; Patch-Clamp Techniques; Protein Transport; Pyramidal Cells; Rats; Receptor, Adenosine A1; Thioinosine | 2017 |
Endogenous adenosine can reduce epileptiform activity in the human epileptogenic cortex maintained in vitro.
Topics: Adenosine; Cerebral Cortex; Epilepsy; Humans; In Vitro Techniques; Thioinosine | 1989 |